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Metallic devices generally represent a contra-indication for MRI scanning. Based on laboratory testing, the neuro cybernetic
prosthesis (NCP) is labelled MRI compatible when used with a send and receive head coil. However, there are no published
clinical data to support the safety of brain MRI in patients with the NCP. Our objective was to report clinical experience with
such a population.
We questioned 40 centres that had implanted the NCP system as of 10/1/99. If MRI had been performed on any vagus nerve
stimulator patients, we collected information on these patients, the MRI technique used, any events noted during the scan,
including both subjective reports (by the patient), and observable (objective) changes noted by the staff.
Twelve centres (30%) responded. Over a time period of 3 years, there were a total of 27 MRI scans performed in 25 patients.
All scanners were 1.5 T. A head coil was used in 26 scans, and a body coil in one. The indications for the scans were diverse.
Seven were related to the epilepsy, including aetiology or pre-surgical evaluation. Others were unrelated, including brain tu-
mours, cerebral haematoma, vasculitis, headaches, and head trauma. Three scans were performed with the stimulator on, while
24 were performed with the stimulator off. One patient had a mild objective voice change for several minutes. No other objec-
tive changes were noted in any of the patients. One 11-year old reported chest pain while experiencing severe claustrophobia.
Twenty-f ve patients denied any discomfort around the lead or the generator.
We conclude that this clinical series supports the safety of routine brain MRI using a send and receive head coil in patients
implanted with the NCP System.
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INTRODUCTION
Since MRI has become widely used, there have been
concerns about the safety of performing MRI in
patients with metallic devices or prostheses. The most
commonly encountered contra-indication to MRI in
clinical practice is the presence of a cardiac pace-
maker1. Other devices that constitute possible contra-
indications to MRI include aneurysm clips, hearing-
aids, and prosthetic limbs2, 3.
In 1997, vagus nerve stimulation (VNS) was ap-
proved for the treatment of medically refractory
localization-related epilepsy4, 5. The neuro cybernetic
prosthesis (NCP) consists of a generator implanted
within the left side of the chest wall, and stimulation
electrodes wrapped around the left vagus nerve. Since
patients who have VNS have medically intractable
epilepsy, they may need an MRI of the brain, which
is a critical part of the pre-surgical evaluation6. In
most cases, patients receiving the NCP have been pre-
viously evaluated for possible epilepsy surgery, and
have therefore undergone a MRI scan. However, it is
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not uncommon for such patients to require another
MRI scan after NCP implantation. Based on labora-
tory testing using a simulated human body, the device
is labelled MRI compatible when used with a send and
receive head coil. However, to date, there are no pub-
lished clinical data to support the safety of performing
brain MRI in patients with the NCP, and the objective
of this case series was to report and describe such a
population.
MATERIALS AND METHODS
We questioned 40 centres that had implanted the NCP
system as of 10/1/99 to determine how many had per-
formed MRI on VNS patients. If MRI was performed,
we collected the following information.
(1) Patient information: age, sex, date of MRI.
(2) MRI information: Equipment brand and model,
magnet strength, whether a head coil was used.
(3) Events noted during the scan, if any, including
both subjective reports (by the patient), and ob-
servable (objective) changes noted by the staff.
RESULTS
Patients
Of 40 centres approached, 12 (30%) responded. Over
a time period of 3 years, there was a total of 27
MRI scans performed in 25 patients. Fourteen patients
were males, and ages ranged from 1 to 52 years (me-
dian 16.5). The indications for the scans were diverse.
Seven were related to the epilepsy, including aetiology
or pre-surgical evaluation. Two patients were scanned
for new onset headache, two for a brain tumour (one
recurrent), one for cerebral haematoma, one for necro-
tizing vasculitis and one for head trauma. Three scans
were performed with the stimulator on, while 24 were
performed with the stimulator off.
Scanners
All scanners were 1.5 T. A head coil was used in 26
scans, and a body coil in one.
Events
One patient had a mild objective voice change for sev-
eral minutes. No other objective changes were noted
in any of the patients. One 11 year-old child reported
chest pain during the MRI, along with severe claus-
trophobia. At this time the MRI was stopped. Because
the MRI technician stated that they were not notifie
of the implant prior to the MRI, no repeat MRI was
performed. Twenty-three patients reported no discom-
fort around the lead or the generator.
DISCUSSION
The potential dangers of performing MRI in patients
implanted with an NCP system are in many ways
comparable to those posed by cardiac pacemakers and
other metallic devices. These concerns are based on
the presence of three phenomena: static fields gradi-
ent fields and the radio-frequency (RF) field gener-
ated by MRI. Static fiel can exert torque and force
on ferromagnetic objects, resulting in displacements,
while RF field can result in excessive heating. Clin-
ically, these two phenomena would be manifested by
the presence of pain. The third phenomenon, gradient
fields could be expected to induce voltage and result
in device stimulation.
In this clinical series, only one of 25 patients re-
ported discomfort or pain. Most (24 of 27) scans were
performed with the stimulator off (as recommended),
but even among the three performed in the on position,
no stimulation was induced.
In vitro experiments have studied the effects of MRI
(1.5 T) on the NCP. Nyhenhuis et al.7 found that
the magnetic forces exerted by the MRI scanner were
0.28 × gravity on the generator and 0.05 × gravity on
the electrodes, and thus unlikely to pose a risk. The
current induced by pulsed gradient field was approx-
imately 0.1 mA (voltage 0.25 V), and thus well below
the 1.5 mA required to trigger the VNS system. Heat-
ing from the RF currents was found to be less than
0.2 ◦C with a 20-minute scan. In addition to these three
safety issues, the same investigators found that there
was no signif cant image distortion. These experimen-
tal findi gs would explain why we did not observe any
of the above theoretical problems. These in vitro find
ings qualify the NCP as both MR safe and MR com-
patible when used with a send and receive head coil in
accordance with the device labelling7, and were con-
firme by our clinical data.
Other implanted neurostimulators such as spine and
brain stimulators have raised similar concerns. These
implanted metallic devices are of particular interest,
since their physical characteristics are comparable to
the NCP. Tronnier8 reported on 38 patients implanted
with Medtronic Itrel II or III pulse generators and
electrodes in the spine or brain who underwent 50
MRI scans. They concluded that MRI can be safely
performed in patients with deep brain leads, but that
further investigations must be performed to study the
local electrical effects in larger plate electrodes, be-
cause these larger plate electrodes in the spine were
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 Magnetic resonance imaging (MRI) should not be performed with a magnetic resonance body coil in the 
transmit mode. The heat induced in the Bipolar Lead by an MRI body scan can cause injury.  
If an MRI should be done, use only a transmit and receive type of head coil. Magnetic and radiofrequency (RF) 
fields produced by MRI may change the Pulse Generator settings (change to reset parameters) or activate the 
device. Stimulation has been shown to cause the adverse events reported in the  
this manual. MRI compatibility was demonstrated using a 1.5 T General Electric Signa Imager only. Testing on 
this imager as performed on a phantom1 indicated that the following Pulse Generator and MRI settings can be 
used safely without adverse events: 
Pulse Generator output programmed to 0 mA for  
the MRI procedure, and afterward, retested by performing the Lead Test diagnostics and reprogrammed to the 
original settings 
Head coil type: transmit and receive only 
Static magnetic field strength:  ≤ 2.0 tesla
Specific-rate absorption (SAR): < 1.3 W/kg for a 154.5-lb (70-kg) patient 
Time-varying intensity: < 10 tesla/sec 
 
Use caution when other MRI systems are used, since adverse events may occur because of 
different magnetic field distributions. 
 No scan in which the radiofrequency (RF) is transmitted by the body coil should be done on a patient who has 
the NCP System. Thus, protocols must not be used which utilize local coils that are RF-receive only, with RF-
transmit performed by the body coil. Note that some  
RF head coils are receive only, and that most other local coils, such as knee and spinal coils, are also RF-
receive only. These coils must not be used in patients with the NCP System. 
 
 
1 A phantom is a material resembling a body in mass, composition, and dimensions that is used to measure absorption of radiation. 
‘Adverse Events’ section of
Fig. 1: Excerpt from Section 5.3.1 of the Physician’s manual.
associated with pain during MRI in some instances.
Another study of an implanted spinal fusion stimula-
tor9 in a full-size human phantom found that whole-
body MRI did not cause heating of the electrodes in
an intact system.
Thus, this clinical case series, like the experimental
data, suggests that MRI using a send and receive head
coil in patients with the NCP system is safe, as long as
the guidelines established in the Physician’s Manual
for the pulse generator10 are followed (Fig. 1).
This study has important clinical implications for
several reasons. Firstly, it is the ﬁrst published series of
patients with the NCP system undergoing MRI. Sec-
ondly, there are many reasons why patients with the
NCP may be in need of a cerebral MRI. (1) VNS may
not prove effective is a sizeable proportion (20–40%)
of patients, so that patients who initially decided to try
VNS may become interested in epilepsy surgery; (2)
patients with the NCP can develop other conditions
such as multiple sclerosis, strokes or brain tumours,
for which MRI is essential; and (3) MRI techniques
are improving rapidly, and consequently the MRI may
need to be repeated. Furthermore, VNS is now being
investigated for other indications, including depres-
sion11. If proved effective and approved, this would
result in an enormous population implanted with VNS,
and therefore greater likelihood of such patients need-
ing an MRI.
We recognize that this report has several limitations.
Firstly, this is a retrospective analysis of a relatively
small sample. Secondly, not all scanning conditions
were tested; for example fMRI may use higher mag-
netic ﬁelds than conventional MRI as may higher ﬁeld
strength MRI than 1.5 T, and therefore may not be as
safe. Finally, only 12 centres responded with infor-
mation. Although one could argue that centres with
more signiﬁcant problems may not have responded,
in general those with problems would be more likely
to report. Therefore, overall, we feel that our series
supports the safety of MRI in patients with the NCP
system.
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